The dialogue that is going on in the Nuclear Energy Agency, and now in a new group that has been established to deal with this matter, is going to look at the short term as a priority and, in the long term, will make sure that there are no systemic obstacles to finding a new source of supply. All the constraints need to be assessed, whether they be economic or related to transportation. The constraints must absolutely be removed so that the projects can come to fruition. That will certainly be the case in North America.
It is interesting to note that the United States, that uses almost half of the world's medical isotopes, has no production capability at the moment. They make generators, but they do not use any of their reactors for the production of medical isotopes. That is also something that we will bring up.